Inveda SRL
19.8 FTEInveda reported total assets of €13.6m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026), with 19.8 full-time equivalents.
The score of Inveda shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -15 % Total assets -31 % Headcount (avg FTE) -29 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inveda's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Inveda's financial analysis
- Solvency48.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inveda
Inveda's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.969.891
- VAT number
- BE0432969891
- Peppol
- Registered · 0208:0432969891 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 1987
- Registered office
- 8400 Ostend
- Size
- Small · 19.8 FTE
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Inveda (SRL) has been based in Ostend since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 594,129 € and equity of €6.64m; its revenue is not published. With 19.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 48.9%, above the median of its sector (44.2%).
Companies similar to Inveda
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Hulsbosch Retail sale of pharmaceutical products Hamont-Achel · balance sheet €14.4m
- Apovlam Retail sale of pharmaceutical products Ypres · balance sheet €11.0m
- Peeters Pharma Retail sale of pharmaceutical products Kinrooi · balance sheet €12.1m
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Coop-Apotheken Retail sale of pharmaceutical products Ghent · balance sheet €31.2m
- Pharmacie Houba Retail sale of pharmaceutical products Brussels · balance sheet €8.75m
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
- DE Weer Buying and selling of own real estate Grimbergen · balance sheet €27.4m
Frequently asked questions about Inveda
What is the revenue of Inveda?
Inveda files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Inveda?
In Belgium, the VAT number is the company number prefixed with BE: BE0432969891 for Inveda, if the company is VAT-registered. Its company number (CBE) is 0432.969.891.
Where is the registered office of Inveda?
According to the CBE register, the registered office of Inveda is in 8400 Ostend.
What is the equity of Inveda?
At the close of the 2025 financial year, the equity of Inveda amounts to 6,640,237 €, a solvency of 48.9% of total assets.
How many people work at Inveda?
19.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Inveda?
The register lists 4 active mandates at Inveda. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inveda
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →